Wealth Enhancement Advisory Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
EB
CPC
AIM
AAMU
AAIS
BCAM
Wealth Enhancement Advisory Services's DGX Position: Q2 2026 in Review
Wealth Enhancement Advisory Services increased its Quest Diagnostics (DGX) stake by 19% in Q2 2026, buying an estimated $523K and bringing the position to 16,842 shares worth $3.15M. The position accounts for 0.01% of the portfolio, ranked #1287.
Wealth Enhancement Advisory Services first reported a position in DGX in Q4 2022 and has held it in 13 quarters since. The position peaked at $5.22M in Q1 2025. 264 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Wealth Enhancement Advisory Services held 16,842 shares of Quest Diagnostics worth $3.15M as of Q2 2026.
- Wealth Enhancement Advisory Services bought 2,663 Quest Diagnostics shares in Q2 2026, an estimated $523K.
- Quest Diagnostics made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1287 holding.
- Wealth Enhancement Advisory Services first reported a position in Quest Diagnostics in Q4 2022 and has held it in 13 quarters since.
- Wealth Enhancement Advisory Services's Quest Diagnostics position peaked at $5.22M in Q1 2025.
- 264 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.